ATE234466T1 - Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten - Google Patents

Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten

Info

Publication number
ATE234466T1
ATE234466T1 AT96934107T AT96934107T ATE234466T1 AT E234466 T1 ATE234466 T1 AT E234466T1 AT 96934107 T AT96934107 T AT 96934107T AT 96934107 T AT96934107 T AT 96934107T AT E234466 T1 ATE234466 T1 AT E234466T1
Authority
AT
Austria
Prior art keywords
detecting
antipolymerantibodies
silicone
test set
diagnostic test
Prior art date
Application number
AT96934107T
Other languages
English (en)
Inventor
Robert F Garry
Scott A Tenenbaum
Douglas R Plymale
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of ATE234466T1 publication Critical patent/ATE234466T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545Synthetic resin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G01N2430/60Synthetic polymers other than synthetic polypeptides as analytes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
AT96934107T 1995-10-20 1996-10-08 Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten ATE234466T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/546,333 US5834215A (en) 1994-10-05 1995-10-20 Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)
PCT/US1996/016107 WO1997014963A1 (en) 1995-10-20 1996-10-08 A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)

Publications (1)

Publication Number Publication Date
ATE234466T1 true ATE234466T1 (de) 2003-03-15

Family

ID=24179940

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934107T ATE234466T1 (de) 1995-10-20 1996-10-08 Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten

Country Status (9)

Country Link
US (1) US5834215A (de)
EP (1) EP0873518B1 (de)
JP (1) JP3630689B2 (de)
AT (1) ATE234466T1 (de)
AU (1) AU710252B2 (de)
CA (1) CA2235316C (de)
DE (1) DE69626683T2 (de)
ES (1) ES2194116T3 (de)
WO (1) WO1997014963A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
ITFI980099A1 (it) * 1998-04-27 1999-10-27 Univ Firenze Metodo diagnostico per patologie algiche
WO2001012839A1 (en) * 1999-08-13 2001-02-22 Berg David E Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response
US6692969B1 (en) 1999-08-13 2004-02-17 David E. Berg Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response
DE60033665T2 (de) * 2000-10-31 2007-10-31 Micronas Gmbh Gemusterte Polymeroberflächen geeignet für Biokonjugationen und Verfahren zu ihrer Herstellung
US7178152B2 (en) * 2001-03-01 2007-02-13 Sony Corporation Application programming interface for communication between audio/video file system and audio video controller
AU2007207089A1 (en) * 2006-01-18 2007-07-26 Wick, Immunologische Diagnostik U. Beratung Kg Test systems for the analysis of polypeptides and cells adhering to silicones
AU2008343138A1 (en) * 2007-12-19 2009-07-09 Great Lakes Biosciences, Llc Brain-related chronic pain disorder diagnosis and assessment method
US8150526B2 (en) 2009-02-09 2012-04-03 Nano-Retina, Inc. Retinal prosthesis
US8706243B2 (en) 2009-02-09 2014-04-22 Rainbow Medical Ltd. Retinal prosthesis techniques
DE202010004193U1 (de) 2010-03-22 2011-05-05 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Testbestecks zur Bestimmung von neuroregulatorischen und psychischen Störungen
DE102011005878A1 (de) 2010-03-22 2011-12-01 Wilfried P. Bieger Verfahren und Testbestecks zur Bestimmung von neuroregulatorischen und psychischen Störungen
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
CN103180731B (zh) * 2010-10-08 2015-09-09 阿克西斯股份有限公司 纤维肌痛症的诊断剂、诊断方法及治疗剂
US8571669B2 (en) 2011-02-24 2013-10-29 Nano-Retina, Inc. Retinal prosthesis with efficient processing circuits
DE102012215515A1 (de) * 2012-08-31 2014-03-06 Klinikum Der Universität München Verfahren zur Detektion von Schäden an Silikonimplantaten und Computertomographiegerät
US9720477B2 (en) 2012-11-21 2017-08-01 Nano-Retina, Inc. Weak power supply operation and control
JP6674759B2 (ja) 2015-10-01 2020-04-01 国立大学法人北海道大学 線維筋痛症の判定のための方法及びキット
US10330686B2 (en) 2016-10-20 2019-06-25 Autoimmune Technologies, Llc Assay for anti-polyvinyl alcohol antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
US4918165A (en) * 1987-07-16 1990-04-17 Ophthalmic Research Corporation Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
EP0324455A3 (de) * 1988-01-15 1991-03-27 Hans O. Ribi Neue polymerische Immuno-Adjuvans
US5340720A (en) * 1989-11-29 1994-08-23 University Of Kansas Methods of diagnosing and monitoring rheumatic diseases
GB9204409D0 (en) * 1992-02-29 1992-04-15 Ciba Geigy Ag Determination method
WO1994020857A1 (en) * 1993-03-11 1994-09-15 The Regents Of The University Of California Assay for humoral immunity to macromolecules

Also Published As

Publication number Publication date
DE69626683T2 (de) 2003-08-28
DE69626683D1 (de) 2003-04-17
WO1997014963A1 (en) 1997-04-24
EP0873518B1 (de) 2003-03-12
ES2194116T3 (es) 2003-11-16
EP0873518A1 (de) 1998-10-28
JPH11513802A (ja) 1999-11-24
US5834215A (en) 1998-11-10
AU7260496A (en) 1997-05-07
AU710252B2 (en) 1999-09-16
JP3630689B2 (ja) 2005-03-16
CA2235316C (en) 2005-12-20
CA2235316A1 (en) 1997-04-24

Similar Documents

Publication Publication Date Title
ATE234466T1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
ATE394658T1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE69510772T2 (de) Verfahren zur quantifizierung von lbp in körperflüssigkeiten
DE69624757D1 (de) Vorrichtung zur Koordinatenermittlung, Verfahren hierzu und Steuervorrichtung für den Rechner
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
DE69621739D1 (de) Verfahren, vorrichtung und system zur bestimmung der änderungen eines prüfkörpers
DE68917399T2 (de) Testvorrichtung und Verfahren zur Protein-Untersuchung.
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE3765150D1 (de) Testtraeger und verfahren zur bestimmung von gerinnungsparametern.
SE9604815D0 (sv) A metod of diagnosis
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
DE3785175T2 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
DE69617568D1 (de) Immunoassay Vorrichtung und Testverfahren zu seiner Verwendung
ES2097158T3 (es) Ensayo funcional para la determinacion de la actividad de proteina s.
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
ATE312914T1 (de) Rdgb-proteine
DE69627352D1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten
DE69618451T2 (de) Verfahren zur feststellung einer allergie
DK0788595T3 (da) Fremgangsmåde til undersögelse af immumkompetance
ATE377944T1 (de) Methode für die behandlung einer hepatitisvirusinfektion
DE69515627D1 (de) Verfahren zur Prüfung von Drahtverbindungen
DE69022585D1 (de) Verfahren und Vorrichtung zur Analyse von Formationsflüssigkeiten.
MY133261A (en) Allergenic proteins of natural rubber latex, their production and use in assays

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0873518

Country of ref document: EP